HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Murine lymphocyte and embryonal carcinoma cell surface antigens recognised by rabbit anti-murine embryonal carcinoma serum.

Abstract
Some recent studies have suggested that murine embryonal carcinoma (EC) cells which lack classical H-2 molecules must express some novel class-I-MHC (major histocompatibility complex) type antigens. We have investigated whether rabbit anti-EC sera may recognize such components. Molecules of 40 and 48 kd were immunoprecipitated from EC cells and lymphocytes. The possibility that these molecules may be coded for by genes in the Qa-Tla locus which contains many MHC class-I genes or pseudogenes was investigated. The 40 and 48 kd molecules were not associated with beta 2-microglobulin on EC cells, nor with each other or other molecules through S-S bonds, although they appeared to have intradisulphide structures. Peptide map analysis suggested that the lymphocyte 40 and 48 kd molecules were related to the EC cell 40 and 48 kd molecules. However, these molecules were different from H-2, Ia or Qa-2 molecules from the same mouse strain.
AuthorsP L Stern, N A Beresford, S M Bell, S Thompson
JournalExperimental cell biology (Exp Cell Biol) Vol. 54 Issue 5-6 Pg. 250-62 ( 1986) ISSN: 0304-3568 [Print] Switzerland
PMID3803690 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Antigens, Surface
  • Disulfides
  • H-2 Antigens
  • Histocompatibility Antigens Class I
  • Immune Sera
  • Q surface antigens
Topics
  • Animals
  • Antigens, Neoplasm (analysis)
  • Antigens, Surface (analysis)
  • Chemical Precipitation
  • Disulfides (analysis)
  • Embryonal Carcinoma Stem Cells
  • H-2 Antigens (immunology)
  • Histocompatibility Antigens Class I
  • Immune Sera (immunology)
  • Lymphocytes (immunology)
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred CBA
  • Neoplastic Stem Cells (immunology)
  • Peptide Mapping
  • Rabbits
  • Teratoma (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: